Australia - English - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: methacrylic acid copolymer; purified talc; silicon dioxide; sodium starch glycollate; stearic acid; iron oxide red; carmellose sodium; carnauba wax; magnesium stearate; titanium dioxide; macrogol 6000; triethyl citrate - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - podophyllotoxin 5 mg/ml; podophyllotoxin 5 mg/ml - topical solution - 5 mg/ml - active: podophyllotoxin 5 mg/ml excipient: ethanol lactic acid purified water sodium lactate active: podophyllotoxin 5 mg/ml excipient: ethanol lactic acid purified water sodium lactate - condyline topical solution is indicated for external condylomata acuminata.

Canada - English - Health Canada

sandoz canada incorporated - tamsulosin hydrochloride - capsule (sustained-release) - 0.4mg - tamsulosin hydrochloride 0.4mg - selective alfa-1-adrenergic blocking agents

Canada - English - Health Canada

sandoz canada incorporated - tamsulosin hydrochloride - tablet (extended-release) - 0.4mg - tamsulosin hydrochloride 0.4mg - selective alfa-1-adrenergic blocking agents

Canada - English - Health Canada

sandoz canada incorporated - memantine hydrochloride - tablet - 10mg - memantine hydrochloride 10mg - miscellaneous central nervous system agents

Canada - English - Health Canada

sandoz canada incorporated - memantine hydrochloride - tablet - 10mg - memantine hydrochloride 10mg - miscellaneous central nervous system agents

Canada - English - Health Canada

sandoz canada incorporated - lansoprazole - capsule (delayed release) - 15mg - lansoprazole 15mg - proton-pump inhibitors

Canada - English - Health Canada

sandoz canada incorporated - lansoprazole - capsule (delayed release) - 30mg - lansoprazole 30mg - proton-pump inhibitors

Israel - English - Ministry of Health

takeda israel ltd - brigatinib - film coated tablets - brigatinib 30 mg - brigatinib - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc)

Israel - English - Ministry of Health

takeda israel ltd - brigatinib - film coated tablets - brigatinib 90 mg - brigatinib - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc)